CTLA4 and neoplasm: Consistently, Vanpouille-Box and co-workers revealed that delivering 24 Gy in three fractions of 8 Gy promotes DC recruitment and CTL infiltration through IFN-β secretion and cGAS-STING pathway activation, enabling synergistic tumour rejection with CTLA-4 blockade therapy.